2. Segment Information and Concentrations

12 Months Ended

Jun. 30, 2016

Segment Reporting [Abstract]

Segment Information and Concentrations

The Company views its operations as three segments: the manufacture and marketing of standard benchtop laboratory equipment for research in university, hospital and industrial laboratories sold primarily through laboratory equipment distributors and laboratory and pharmacy balances and scales (“Benchtop Laboratory Equipment Operations”), the manufacture and marketing of custom-made catalyst research instruments for universities, government laboratories, and chemical and petrochemical companies sold on a direct basis (“Catalyst Research Instruments Operations”) and the design and marketing of bioprocessing systems and products and related royalty income (“Bioprocessing Systems”).

Segment information is reported as follows:

	Benchtop  Laboratory  Equipment		Catalyst  Research  Instruments		Bioprocessing  Systems			Corporate  and  Other		Consolidated
June 30, 2016:
Revenues	$	5,449,700	$	4,032,800	$	115,100		$	-	$	9,597,600
Foreign Sales		2,414,600		2,674,300		-			-		5,088,900
Income (Loss) From Operations		223,800		479,500479,500		(458,300	)		-		245,000
Assets		4,120,700		2,292,100		429,900			706,600		7,549,300
Long-Lived Asset
Expenditures		92,500		4,0004,000		9,400			-		105,900
Depreciation, Amortization and Impairment		299,000		31,900		310,700			-		641,600

	Benchtop  Laboratory  Equipment		Catalyst  Research  Instruments		Bioprocessing  Systems			Corporate  and  Other		Consolidated
June 30, 2015:
Revenues	$	5,410,500	$	2,315,900	$	122,000		$	-	$	7,848,400
Foreign Sales		2,584,100		1,322,400		-			-		3,906,500
Income (Loss) From Operations		90,600		19,700		(127,100	)		-		(16,800	)
Assets		4,240,100		1,614,400		736,400			550,500		7,141,400
Long-Lived Asset
Expenditures		65,300		1,000		7,600			-		73,900
Depreciation and Amortization		302,000		34,800		98,000			-		434,800

During the year ended June 30, 2016, one customer accounted for approximately 26% of total revenues.